Intranasal B5 promotes mucosal defence against Actinobacillus pleuropneumoniae via ameliorating early immunosuppression

References

• Gottschalk M, Broes A. Actinobacillosis. In Zimmerman JJ, Karriker LA, Ramirez A, et al., editors. Diseases of swine. Chichester: Wiley; 2019. p. 749–17.
   Google Scholar
• Sassu EL, Bossé JT, Tobias TJ, et al. Update on Actinobacillus pleuropneumoniae-knowledge, gaps and challenges. Transbound Emerg Dis. 2018;1:72–90. doi: 10.1111/tbed.12739
   Google Scholar
• Qi W, Zhu R, Bao C, et al. Porcine circovirus type 2 promotes Actinobacillus pleuropneumoniae survival during coinfection of porcine alveolar macrophages by inhibiting ROS production. Vet Microbiol. 2019;233:93–101. doi: 10.1016/j.vetmic.2019.04.028
   PubMed Web of Science ®Google Scholar
• Stringer OW, Bossé JT, Lacouture S, et al. Proposal of Actinobacillus pleuropneumoniae serovar 19, and reformulation of previous multiplex PCRs for capsule-specific typing of all known serovars. Veterinary Microbiology. 2021;255:109021. doi: 10.1016/j.vetmic.2021.109021
   PubMed Web of Science ®Google Scholar
• Kardos G, Sárközi R, Laczkó L, et al. Genetic Diversity of Actinobacillus pleuropneumoniae Serovars in Hungary[J]. Vet Sci. 2022;9(10):511. doi: 10.3390/vetsci9100511
   PubMedGoogle Scholar
• Shunsuke K, Toshiya S, Hiroya I. Serovar and antimicrobial resistance profiles of actinobacillus pleuropneumoniae isolated in Japan from 2006 to 2011. JARQ. 2016;50(1):73–77. doi: 10.6090/jarq.50.73
   Google Scholar
• Nahar N, Turni C, Tram G, et al. Actinobacillus pleuropneumoniae: The molecular determinants of virulence and pathogenesis[J]. Adv Microb Physiol. 2021;78:179–216.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Martín CB, Blanco N G D, Blanco M, et al. Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade[J]. Vet Microbiol. 2006;115(1–3):218–222. doi: 10.1016/j.vetmic.2005.12.014
   PubMed Web of Science ®Google Scholar
• Vilaró A, Novell E, Enrique-Tarancón V, et al. Antimicrobial Susceptibility Pattern of Porcine Respiratory Bacteria in Spain[J]. Antibiotics. 2020;9(7):402. doi: 10.3390/antibiotics9070402
   Google Scholar
• Rao J, Wei X, Li H, et al. Novel multiplex PCR assay and its application in detecting prevalence and antibiotic susceptibility of porcine respiratory bacterial pathogens in Guangxi, China. Microbiol Spectr. 2023;11(2):e0397122. doi: 10.1128/spectrum.03971-22
   PubMed Web of Science ®Google Scholar
• Chiers K, De Waele T, Pasmans F, et al. Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host. Vet Res. 2010;41(5):65. doi: 10.1051/vetres/2010037
   PubMed Web of Science ®Google Scholar
• Bercier P, Gottschalk M, Grenier D. Effects of Actinobacillus pleuropneumoniae on barrier function and inflammatory response of pig tracheal epithelial cells. Pathog Dis. 2019;77(1):fty079. doi: 10.1093/femspd/fty079
   PubMed Web of Science ®Google Scholar
• Gao N, Rezaee F. Airway epithelial cell junctions as targets for pathogens and antimicrobial therapy. Pharmaceutics. 2022;14(12):2619. doi: 10.3390/pharmaceutics14122619
   PubMed Web of Science ®Google Scholar
• Counoupas C, Ferrell KC, Ashhurst A, et al. Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis[J]. NPJ Vaccin. 2020;5(1):105. doi: 10.1038/s41541-020-00255-7
   PubMed Web of Science ®Google Scholar
• Eiden J, Fierro C, Schwartz H, et al. Intranasal M2SR (M2-deficient single replication) H3N2 influenza vaccine provides enhanced mucosal and serum antibodies in Adults. J Infect Dis. 2022;227(1):103–112. doi: 10.1093/infdis/jiac433
   PubMed Web of Science ®Google Scholar
• Deng S, Liu Y, Tam RC, et al. An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters. Nat Commun. 2023;14(1):2081. doi: 10.1038/s41467-023-37697-1
   PubMed Web of Science ®Google Scholar
• Figueiredo DB, Kaneko K, Rodrigues TDC, et al. Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs[J]. Pharmaceutics. 2022;14(6):1238. doi: 10.3390/pharmaceutics14061238
   PubMed Web of Science ®Google Scholar
• Cabral MP, Correia A, Vilanova M, et al. A live auxotrophic vaccine confers mucosal immunity and protection against lethal pneumonia caused by Pseudomonas aeruginosa[J]. PLOS Pathog. 2020;16(2):e1008311. doi: 10.1371/journal.ppat.1008311
   PubMed Web of Science ®Google Scholar
• Kim GL, Lee S, Kim SJ, et al. Pulmonary colonization resistance to pathogens via noncanonical wnt and interleukin-17A by intranasal pep27 mutant Immunization. The Journal Of Infectious Diseases. 2018;217(12):1977–1986. doi: 10.1093/infdis/jiy158
   PubMed Web of Science ®Google Scholar
• Galeas-Pena M, Mclaughlin N, Pociask D. The role of the innate immune system on pulmonary infections. Biol Chem. 2019;400(4):443–456. doi: 10.1515/hsz-2018-0304
   PubMed Web of Science ®Google Scholar
• Bao C, Liu B, Zhu R, et al. IFN-γ(-/-) mice resist Actinobacillus pleuropneumoniae infection by promoting early lung IL-18 release and PMN-I Accumulation. Infect Immun. 2021;89(6):e00069–21. doi: 10.1128/IAI.00069-21
   PubMed Web of Science ®Google Scholar
• Hiemstra PS, Amatngalim GD, Van Der Does AM, et al. Antimicrobial peptides and innate lung defenses: role in infectious and noninfectious lung diseases and therapeutic Applications. Chest. 2016;149(2):545–551. doi: 10.1378/chest.15-1353
   PubMed Web of Science ®Google Scholar
• Mookherjee N, Anderson MA, Haagsman HP, et al. Antimicrobial host defence peptides: functions and clinical potential[J]. Nat Rev Drug Discov. 2020;19(5):311–332. doi: 10.1038/s41573-019-0058-8
   PubMed Web of Science ®Google Scholar
• Gao X, Ding J, Liao C, et al. Defensins: The natural peptide antibiotic[J]. Adv Drug Deliv Rev. 2021;179:114008. doi: 10.1016/j.addr.2021.114008
   PubMed Web of Science ®Google Scholar
• Huang C, Yang X, Huang J, et al. Porcine beta-defensin 2 provides protection against bacterial infection by a direct bactericidal activity and alleviates inflammation via interference with the TLR4/NF-κB pathway. Front Immunol. 2019;10:1673. doi: 10.3389/fimmu.2019.01673
   PubMed Web of Science ®Google Scholar
• Yang X, Cheng YT, Tan MF, et al. Overexpression of porcine beta-defensin 2 enhances resistance to Actinobacillus pleuropneumoniae infection in pigs. Infect Immun. 2015;83(7):2836–2843. doi: 10.1128/IAI.03101-14
   PubMed Web of Science ®Google Scholar
• Huang J, Yang X, Wang A, et al. Pigs Overexpressing Porcine β-Defensin 2 Display Increased Resilience to Glaesserella parasuis Infection[J]. Antibiotics. 2020;9(12):903. doi: 10.3390/antibiotics9120903
   Google Scholar
• Lee EY, Lee MW, Wong GCL. Modulation of toll-like receptor signaling by antimicrobial peptides. Semin Cell Dev Biol. 2019;88:173–184. doi: 10.1016/j.semcdb.2018.02.002
   PubMed Web of Science ®Google Scholar
• Liang Z, Li H, Qu M, et al. Intranasal bovine β-defensin-5 enhances antituberculosis immunity in a mouse model by a novel protein-based respiratory mucosal vaccine[J]. Virulence. 2022;13(1):949–962. doi: 10.1080/21505594.2022.2080342
   PubMed Web of Science ®Google Scholar
• Dong X, Limjunyawong N, Sypek EI, et al. Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin dysbiosis and bacterial infection. Immunity. 2022;55(9):1645–1662. doi: 10.1016/j.immuni.2022.06.021
   PubMed Web of Science ®Google Scholar
• Ryan LK, Wu J, Schwartz K, et al. β-defensins coordinate in vivo to inhibit bacterial infections of the Trachea. Vaccines (Basel). 2018;6(3):57. doi: 10.3390/vaccines6030057
   PubMed Web of Science ®Google Scholar
• Liang Z, Liu Y, Sun X, et al. Immunoregulatory and antimicrobial activity of bovine neutrophil β-defensin-5-loaded PLGA nanoparticles against Mycobacterium bovis. Pharmaceutics. 2020;12(12):1172. doi: 10.3390/pharmaceutics12121172
   PubMed Web of Science ®Google Scholar
• Song Y, Ge X, Chen Y, et al. Mycobacterium bovis induces mitophagy to suppress host xenophagy for its intracellular survival. Autophagy. 2022;18(6):1401–1415. doi: 10.1080/15548627.2021.1987671
   PubMed Web of Science ®Google Scholar
• Jung ID, Shin SJ, G LM, et al. Enhancement of tumor-specific T cell-mediated immunity in dendritic cell-based vaccines by Mycobacterium tuberculosis heat shock protein X. J Immunol. 2014;193(3):1233–1245. doi: 10.4049/jimmunol.1400656
   PubMed Web of Science ®Google Scholar
• Bao C, Jiang H, Zhu R, et al. Differences in pig respiratory tract and peripheral blood immune responses to Actinobacillus pleuropneumoniae. Vet Microbiol. 2020;247:108755. doi: 10.1016/j.vetmic.2020.108755
   PubMed Web of Science ®Google Scholar
• Gonzalez-Ferrer S, Peñaloza HF, Budnick JA, et al. Finding Order in the Chaos: Outstanding Questions in Klebsiella pneumoniae Pathogenesis[J]. Infect Immun. 2021;89(4):e00693–20. doi: 10.1128/IAI.00693-20
   PubMed Web of Science ®Google Scholar
• Hoffmann JP, Kolls JK, Mccombs JE. Regulation and function of ILC3s in pulmonary Infections. Front Immunol. 2021;12:672523. doi: 10.3389/fimmu.2021.672523
   PubMed Web of Science ®Google Scholar
• Stehle C, Hernández DC, Romagnani C. Innate lymphoid cells in lung infection and immunity. Immunol Rev. 2018;286(1):102–119. doi: 10.1111/imr.12712
   PubMed Web of Science ®Google Scholar
• Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363(23):2233–2247. doi: 10.1056/NEJMra0910061
   PubMed Web of Science ®Google Scholar
• Cruijsen TL, Leengoed L A V, Dekker-Nooren TC, et al. Phagocytosis and killing of Actinobacillus pleuropneumoniae by alveolar macrophages and polymorphonuclear leukocytes isolated from pigs. Infect Immun. 1992;60(11):4867–4871. doi: 10.1128/iai.60.11.4867-4871.1992
   PubMed Web of Science ®Google Scholar
• Hennig-Pauka I, Koch R, Hoeltig D, et al. PR-39, a porcine host defence peptide, is prominent in mucosa and lymphatic tissue of the respiratory tract in healthy pigs and pigs infected with Actinobacillus pleuropneumoniae. BMC Res Notes. 2012;5(1):539. doi: 10.1186/1756-0500-5-539
   PubMedGoogle Scholar
• Hennig-Pauka I, Jacobsen I, Blecha F, et al. Differential proteomic analysis reveals increased cathelicidin expression in porcine bronchoalveolar lavage fluid after an Actinobacillus pleuropneumoniae infection. Vet Res. 2006;37(1):75–87. doi: 10.1051/vetres:2005043
   PubMed Web of Science ®Google Scholar
• Xie F, Wang Y, Li G, et al. The SapA Protein Is Involved in Resistance to Antimicrobial Peptide PR-39 and Virulence of Actinobacillus pleuropneumoniae[J]. Front Microbiol. 2017;8:811. doi: 10.3389/fmicb.2017.00811
   PubMed Web of Science ®Google Scholar
• Lazzaro BP, Zasloff M, Rolff J. Antimicrobial peptides: application informed by evolution. Science. 2020;368(6490):eaau5480. doi: 10.1126/science.aau5480
   PubMed Web of Science ®Google Scholar
• Li B, Fang J, Zuo Z, et al. Activation of porcine alveolar macrophages by Actinobacillus pleuropneumoniae lipopolysaccharide via the toll-like receptor 4/nf-κb-mediated pathway. Infect Immun. 2018;86(3):e00642–17. doi: 10.1128/IAI.00642-17
   PubMed Web of Science ®Google Scholar
• McAleer JP, Kolls JK. Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense. Immunol Rev. 2014;260(1):129–144. doi: 10.1111/imr.12183
   PubMed Web of Science ®Google Scholar
• Kumaran Satyanarayanan S, El Kebir D, Soboh S, et al. IFN-β is a macrophage-derived effector cytokine facilitating the resolution of bacterial inflammation. Nat Commun. 2019;10(1):3471. doi: 10.1038/s41467-019-10903-9
   PubMedGoogle Scholar
• Boxx GM, Cheng G. The roles of type I interferon in bacterial infection. Cell Host Microbe. 2016;19(6):760–769. doi: 10.1016/j.chom.2016.05.016
   PubMed Web of Science ®Google Scholar
• Sekheri M, Rizo-Téllez SA, Othman A, et al. Interferon-β regulates proresolving lipids to promote the resolution of acute airway inflammation. Proc Natl Acad Sci USA. 2022;119(31):e2201146119. doi: 10.1073/pnas.2201146119
   PubMed Web of Science ®Google Scholar
• Boxx GM, Cheng G. The roles of type I interferon in bacterial Infection [J]. Cell Host Microbe. 2016;19(6):760–769.
   PubMed Web of Science ®Google Scholar